JUAN JOSÉ
PICAZO DE LA GARZA
Investigador en el periodo 2009-2018
Publicaciones (191) Publicaciones de JUAN JOSÉ PICAZO DE LA GARZA
2022
-
Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates
Enfermedades infecciosas y microbiologia clinica (English ed.), Vol. 40, Núm. 4, pp. 172-178
2020
-
Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates
Enfermedades Infecciosas y Microbiologia Clinica
2019
2018
-
Effects of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants aged 0 to 90 days in Madrid, Spain
Journal of the Pediatric Infectious Diseases Society
2017
-
Characterization and circulation of seasonal influenza viruses in Madrid, 2010-2016
Journal of Medical Virology, Vol. 89, Núm. 10, pp. 1726-1733
-
Consenso sobre la vacunación anti-neumocócica en el adulto por riesgo de edad y patología de base. Actualización 2017
Revista Espanola de Quimioterapia, Vol. 30, Núm. 2, pp. 142-168
-
Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing enterobacteriaceae
Journal of Medical Microbiology, Vol. 66, Núm. 2, pp. 169-174
-
Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015
PLoS ONE, Vol. 12, Núm. 2
-
Epidemiology of otitis media with spontaneous perforation of the tympanic membrane in young children and association with bacterial nasopharyngeal carriage, recurrences and pneumococcal vaccination in Catalonia, Spain - The prospective hermes study
PLoS ONE, Vol. 12, Núm. 2
-
Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children
Vaccine, Vol. 35, Núm. 35, pp. 4646-4651
-
In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents
International Journal of Antimicrobial Agents, Vol. 50, Núm. 2, pp. 191-196
-
Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2
2016
-
Compendio de microbiología
ed. lit.
Elsevier
-
Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses
Journal of Medical Microbiology, Vol. 65, Núm. 6, pp. 456-461
2015
-
Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 10, pp. 5959-5966
-
Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates
Microbial Drug Resistance
-
Comparison of NITAG policies and working processes in selected developed countries
Vaccine, Vol. 33, Núm. 1, pp. 3-11
-
Could ceftaroline be an alternative therapy for linezolid resistant staphylococcus epidermidis infections in intensive care medicine?
Revista Espanola de Quimioterapia, Vol. 28, Núm. 4, pp. 214-216
-
El desarrollo de nuevas vacunas
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 8, pp. 557-568
-
In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains
International Journal of Antimicrobial Agents